At Sensei Biotherapeutics, our goal is to understand and selectively interact with the tumor microenvironment in order to tilt the immune system against cancer. The Sensei team brings together leaders with deep expertise in our core disciplines, along with a highly accomplished team of life science business leaders. Collectively our team members have driven dozens of programs into clinical studies and played key roles in developing some of the world’s leading immuno-oncology drugs.

Leadership Team


John K. Celebi, MBA

President & Chief Executive Officer


Erin Colgan

Chief Financial Officer

headshots male2

Patrick Gallagher, MBA, MPH

Chief Business Officer


Robert Pierce, M.D.

Chief R&D Officer


Edward van der Horst, Ph.D.

Senior Vice President, Biologics Discovery & Early Development


Hanspeter Waldner, Ph.D.

Senior Vice President, Immunology & Translational Medicine


Elisabeth Colunio

Vice President, Human Resources


Alice Drumheller

Vice President, Clinical Operations


Bao Le

Vice President, Regulatory Affairs


Humberto Moran

Vice President, Technical Operations & Maryland Site Lead

Board of Directors

William Ringo, MBA

Board Chair

Samuel Broder, M.D.

John K. Celebi, MBA

Jessie English, Ph.D.

Bob Holmen, J.D.

Kristian Humer, MBA

James Peyer, Ph.D.

Tom Ricks, MBA

Deneen Vojta, M.D.

Immuno-Oncology Advisory Board

Alain Algazi, M.D.

Stephen Dewhurst, Ph.D.

Maura Gillison, M.D., Ph.D.

Sara Pai, M.D., Ph.D.

Robert Schreiber, Ph.D.

Daniel H. Sterman, M.D.

Richard Ulevitch, Ph.D.

HQ: 451 D St, Unit 710 , Boston, MA 02210

MD: 1405 Research Blvd, Suite 125,
Rockville, MD 20850